News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Ferran Headshot socio fundador
#NewAseBioMember | "We believe that AseBio can serve as an important tool for expanding collaborations"
Healthcare · Corporate
Meet our new member MedBioinformatics. We sponke with Ferran Sanz, Founding Partner, Member of the…
AseBio - MEDBIOINFORMATICS SOLUTIONS
CEOs de las empresas Nuage Therapeutics, Ona Therapeutics y SpliceBio
Nuage Therapeutics, Ona Therapeutics, and SpliceBio are leading the wave of biotech innovation in Barcelona
Healthcare · Rare diseases · Personalized medicine · Advanced therapies
Las biotecnológicas Nuage Therapeutics, Ona Therapeutics y SpliceBio, con sede en el Parque…
Partners - Parc Científic de Barcelona
Thumbnail
John Nicols joins ZYMVOL’s board of directors
Corporate
Partners - Zymvol Biomodeling
Estudios Gate2Brain
Validation of Gate2Brain Technology in the Transport of Antibodies to the Brain Opens the Avenue of the Next Generation of CNS Therapeutics with Improved Delivery to the Brain
Healthcare · Innovative drugs
Together, these studies reinforce the concept that advanced peptide-based brain shuttle…
Partners - Gate2Brain
Científica observando a través de un microscopio
deepull secures oversubscribed €50 million Series C financing to advance UllCORE diagnostic system for direct-from-blood rapid pathogen detection
Healthcare · Access to innovation · Financing
Round co-led by Columbus Venture Partners, Panakès Partners and Mérieux Equity Partners
Partners - Asabys Partners
Presentación BIOSPAIN Madrid
BIOSPAIN 2025: The Role of the Biotechnology Industry in the EU’s Strategic Autonomy
BioSpain
Under the motto “Global crossroads, local vibes”, the event aims to connect local talent with…
La sede de Oryzon
ORYZON capta 30 millones de euros en una ampliación de capital internacional
Financing
Priced at €2.35 per share, representing a 15.44% discount on the 5-day VWAP
Partners - Oryzon Genomics
Sede de ORYZON
ORYZON continues to strengthen its patent portfolio for vafidemstat
Healthcare · Innovative drugs
Oryzon secures new patents in Europe and Japan for vafidemstat, extending protection until 2040 for…
Partners - Oryzon Genomics
Maria_Jose_Aliaga_Gosalvez
#NewAseBioMember | “Being part of AseBio means joining a dynamic community committed to advancing biotechnology in Spain and beyond”
Corporate
Meet our new member Schrödinger. We sponke with María José Aliaga, Associate Account Manager.